Clinical Trial Update: Paclitaxel and Carboplatin in Women With Malignant Mixed Mullerian Tumors (MMMT) of the Uterus [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating paclitaxel plus carboplatin for malignant mixed Müllerian tumors of the uterus has completed, with results posted in January 2012.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Malignant Mixed Müllerian Tumor of the Uterus

Drugs mentioned

• Paraplatin (Carboplatin)
• Taxol (paclitaxel)

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Mixed Tumor, Mullerian | Phase 2 | Status: COMPLETED | Results posted: 2012-01-09